Adam Brown - Health Catalyst Senior Analysis
| HCAT Stock | USD 3.63 0.11 3.12% |
Executive
Adam Brown is Senior Analysis of Health Catalyst
| Phone | 801 708 6800 |
| Web | https://www.healthcatalyst.com |
Health Catalyst Management Efficiency
The company has return on total asset (ROA) of (0.0415) % which means that it has lost $0.0415 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.198) %, meaning that it created substantial loss on money invested by shareholders. Health Catalyst's management efficiency ratios could be used to measure how well Health Catalyst manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Matthew Ruderman | Definitive Healthcare Corp | N/A | |
| Ram Sharma | Definitive Healthcare Corp | N/A | |
| Steven Smits | Live Oak Bancshares, | 58 | |
| Kyle Triplett | Appfolio | N/A | |
| Carrie Lazorchak | Definitive Healthcare Corp | 54 | |
| Michelle Liro | Definitive Healthcare Corp | N/A | |
| Dawn Severance | TruBridge | 55 | |
| Ashwin Uttamchandani | Phreesia | N/A | |
| Kevin JD | HealthStream | 55 | |
| Tia Padia | HealthEquity | N/A | |
| Matthew Baird | Appfolio | N/A | |
| Hannah Jones | Certara | N/A | |
| Walter Phifer | Live Oak Bancshares, | 40 | |
| Claire Parker | Live Oak Bancshares, | N/A | |
| Janet MD | Progyny | N/A | |
| Steve Lindsay | HealthEquity | N/A | |
| Vince Coley | Appfolio | N/A | |
| Mary Delano | Definitive Healthcare Corp | N/A | |
| Risa Fisher | Progyny | N/A | |
| RN BSN | HealthStream | 49 | |
| Arielle Bogorad | Progyny | N/A | |
Management Performance
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.0415 |
Health Catalyst Leadership Team
Elected by the shareholders, the Health Catalyst's board of directors comprises two types of representatives: Health Catalyst inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Health. The board's role is to monitor Health Catalyst's management team and ensure that shareholders' interests are well served. Health Catalyst's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Health Catalyst's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neil Andersen, Western Accounts | ||
| Kevin Freeman, Chief Officer | ||
| Paul Horstmeier, Chief Officer | ||
| Adam Brown, Senior Analysis | ||
| Jeffrey Selander, Senior International | ||
| Daniel LeSueur, Chief Officer | ||
| Jason Jones, Chief Platform | ||
| T Elbert, Chief VP | ||
| BSN MBA, Eastern Accounts | ||
| Daniel Burton, CEO Director | ||
| Daniel Orenstein, Senior Advisor | ||
| Kristen Berry, Senior Relations | ||
| Maxine Liu, Senior Interopability | ||
| Holly Rimmasch, Senior Officer | ||
| Tarah Bryan, Chief Officer | ||
| Ryan Barry, Chief Services | ||
| Kyle Salyers, Chief Development | ||
| Kevin Scharnhorst, Chief Officer | ||
| Leslie Falk, Chief Officer | ||
| Benjamin Landry, General Board | ||
| Bryan Hunt, Senior Advisor | ||
| MPH DDS, GM Business | ||
| Linda Llewelyn, Chief Officer | ||
| Amanda Flanders, Senior Communications | ||
| Dave Ross, Chief Officer | ||
| Patrick Nelli, Advisor | ||
| Jason Alger, Chief Officer | ||
| Lynne MPH, Senior Growth | ||
| Dan Heinmiller, Senior Services |
Health Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Health Catalyst a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.0415 | ||||
| Profit Margin | (0.23) % | ||||
| Operating Margin | (0.17) % | ||||
| Current Valuation | 304.7 M | ||||
| Shares Outstanding | 69.6 M | ||||
| Shares Owned By Insiders | 3.49 % | ||||
| Shares Owned By Institutions | 81.78 % | ||||
| Number Of Shares Shorted | 3.74 M | ||||
| Price To Earning | (2.62) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.